...Thank you for waiting, everybody. We'll now start Daiichi Sankyo's ASCO 2025 highlights. This is Ken Asakura from Corporate Communications, and I will be the moderator today. First, about the language for this event. Presentation will be in English, and Q&A will be in both English and Japanese. Simultaneous interpretation is provided, so please click the interpretation icon at the bottom of the screen and select either English, Japanese or original audio. When original audio is selected, you will hear the original sound. English presentation slides will be shown on the Zoom screen as well as live streaming screen. The slides have been uploaded to IR Presentation Materials page of Investors section on our corporate website, so please view or download as needed. Our presenter for today is Dr. Mark Rutstein, our Head of Therapeutic Area Oncology Development. We will take questions after the presentation. Mr. Hiroyuki Okuzawa, our President and CEO, will open the meeting, and will join for...